Quercetin in periodontitis

About this trial

Last updated a year ago

Study ID

Status

Not yet recruiting

Type

Interventional

Phase

Phase 1

Placebo

Accepting

18 to 65 Years

All

Not accepting

Healthy Volunteers

Trial Timing

Ended a year ago

Periodontitis is an immune-inflammatory disease affecting the supporting structures of the teeth. It is a disease of multifactorial etiology, with microbial, genetic, environmental and host factors involved, with the release of oxygen-free radicals by the inflammatory cells. Quercetin, have shown potential antimicrobial activity, lowering of inflammatory markers, cholesterol reduction and inhibiting bone loss. However, this data has largely been obtained from in vitro and animal studies, but data from human studies are limited.

Inclusion Criteria:

- Inclusion criteria:

- Patients with periodontitis stage ( Ⅰ & Ⅱ ). Stage I have CAL 1 to 2mm with no
tooth loss and probing depth ≤4 mm. Stage II have CAL 3 to 4mm with no tooth
loss and probing depth ≤5 mm..

- Patients who have teeth with both mesial and distal neighboring teeth .

- Patient with more than 20 natural teeth .

- Patient free from any systemic disease that may effect the periodontal status
according to the criteria of Cornell Medical Index and its modification.

Exclusion Criteria:

- Long-term therapy with medications within a month prior to enrollment that could
affect periodontal status or healing.

- Pregnant woman and lactating mothers .

- Patients with a history of traumatic occlusion.

- Teeth with both endo-perio lesion .

- Patients with previous periodontal treatment including scaling and root planing and
periodontal surgery in the last 3 and 6 months, respectively .

Effect of Quercetin in Treatment of Periodontitis